相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with metastatic neuroendocrine tumours: a systematic review and meta-analysis
Jie Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Preclinical PET imaging of bispecific antibody ERY974 targeting CD3 and glypican 3 reveals that tumor uptake correlates to T cell infiltrate
Stijn J. H. Waaijer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A review of cancer immunotherapy: from the past, to the present, to the future
K. Esfahani et al.
CURRENT ONCOLOGY (2020)
Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models
Thomas A. Burley et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer
M. Ankersmit et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Digital PET/CT: a new intriguing chance for clinical nuclear medicine and personalized molecular imaging
Orazio Schillaci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors
C. Willemien Menke-van der Houven van Oordt et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Phase I/IIa PET imaging study with 89zirconium labeled anti-PSMA minibody for urological malignancies
Akira Joraku et al.
ANNALS OF NUCLEAR MEDICINE (2019)
An overview of nanoscale radionuclides and radiolabeled nanomaterials commonly used for nuclear molecular imaging and therapeutic functions
Leila Farzin et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2019)
EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer
Francisco Sanchez-Vega et al.
CANCER DISCOVERY (2019)
Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89
Chuangyan Zhai et al.
BIOMOLECULES (2019)
Zr-89-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
Christopher G. England et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using Zr-89-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Multiregional Tumor Drug-Uptake Imaging by PET and Microvascular Morphology in End-Stage Diffuse Intrinsic Pontine Glioma
Sophie E. M. Veldhuijzen van Zanten et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Long-Half-Life 89Zr-Labeled Radiotracers Can Guide Percutaneous Biopsy Within the PET/CT Suite Without Reinjection of Radiotracer
Francois H. Cornelis et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Pharmacokinetics, Biodistribution, and Radiation Dosimetry for 89Zr-Trastuzumab in Patients with Esophagogastric Cancer
Joseph A. O'Donoghue et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Thiol-Reactive Bifunctional Chelators for the Creation of Site-Selectively Modified Radioimmunoconjugates with Improved Stability
Pierre Adumeau et al.
BIOCONJUGATE CHEMISTRY (2018)
Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer
Farrokh Dehdashti et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging
Carlos D. Martins et al.
CLINICAL CANCER RESEARCH (2018)
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Chloe J. Peach et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Potential use of prostate specific membrane antigen (PSMA) for detecting the tumor neovasculature of brain tumors by PET imaging with 89Zr-Df-IAB2M anti-PSMA minibody
Masahide Matsuda et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89Zr-Oxine
Michael R. Weist et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Recent Advances in Zirconium-89 Chelator Development
Nikunj B. Bhatt et al.
MOLECULES (2018)
Zr-89 for antibody labeling and in vivo studies - A comparison between liquid and solid target production
Gemma M. Dias et al.
NUCLEAR MEDICINE AND BIOLOGY (2018)
Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors
Denis R. Beckford Vera et al.
PLOS ONE (2018)
Hepatocyte spheroids as an alternative to single cells for transplantation after ex vivo gene therapy in mice and pig models
Clara T. Nicolas et al.
SURGERY (2018)
89Zr-nimotuzumab for immunoPET imaging of epidermal growth factor receptor I
Rufeal Chekol et al.
Oncotarget (2018)
Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
Derrek A. Heuveling et al.
EJNMMI RESEARCH (2018)
PSMA Theranostics: Current Status and Future Directions
Kambiz Rahbar et al.
MOLECULAR IMAGING (2018)
The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
Zijun Zhao et al.
ACTA PHARMACEUTICA SINICA B (2018)
89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
Frederike Bensch et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
Frederike Bensch et al.
NATURE MEDICINE (2018)
Application of Immuno-PET in Antibody-Drug Conjugate Development
Kendra S. Carmon et al.
MOLECULAR IMAGING (2018)
Molecular Drug Imaging: 89Zr-Bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma
Marc H. Jansen et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach
Aniek J. G. Even et al.
ONCOTARGET (2017)
89Zr-Bevacizumab PET: Potential Early Indicator of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma
Suzanne C. van Es et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Multifunctional Desferrichrome Analogues as Versatile 89Zr(IV) Chelators for ImmunoPET Probe Development
Casey J. Adams et al.
MOLECULAR PHARMACEUTICS (2017)
Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
Yvonne W. S. Jauw et al.
PLOS ONE (2017)
In-depth Characterization of a TCR-specific Tracer for Sensitive Detection of Tumor-directed Transgenic T Cells by Immuno-PET
Nahid Yusufi et al.
THERANOSTICS (2017)
Rational Design, Development, and Stability Assessment of a Macrocyclic Four-Hydroxamate-Bearing Bifunctional Chelating Agent for 89Zr
Uwe Seibold et al.
CHEMMEDCHEM (2017)
89Zr-Trastuzumab PET/CT for Detection of Human Epidermal Growth Factor Receptor 2-Positive Metastases in Patients With Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer
Gary A. Ulaner et al.
CLINICAL NUCLEAR MEDICINE (2017)
89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors
Frederike Bensch et al.
CLINICAL CANCER RESEARCH (2017)
A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of 89zirconium for positron emission tomography (PET) imaging
Christian Buchwalder et al.
DALTON TRANSACTIONS (2017)
Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis
Thijs J. Beldman et al.
ACS NANO (2017)
Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of 89Zr-labeled antibodies
Julie Rousseau et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Siderophores for molecular imaging applications
Milos Petrik et al.
CLINICAL AND TRANSLATIONAL IMAGING (2017)
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
G. Gebhart et al.
ANNALS OF ONCOLOGY (2016)
Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy
Anyanee Karnkaew et al.
ACS NANO (2016)
89Zr-rituximab PET/CT to detect neurolymphomatosis
Antoinette de Jong et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Spot-welding solid targets for high current cyclotron irradiation
Paul A. Ellison et al.
APPLIED RADIATION AND ISOTOPES (2016)
HDL mimetic CER-001 targets atherosclerotic plaques in patients
Kang He Zheng et al.
ATHEROSCLEROSIS (2016)
89Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease
Sjoukje F. Oosting et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Detection of HER2-Positive Metastases in Patients with HER2-Negative Primary Breast Cancer Using 89Zr-Trastuzumab PET/CT
Gary A. Ulaner et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy
Benjamin M. Larimer et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast Cancer
Richard Laforest et al.
MOLECULAR IMAGING AND BIOLOGY (2016)
Improved production and processing of Zr-89 using a solution target
Mukesh K. Pandey et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Tracking and Therapeutic Value of Human Adipose Tissue-derived Mesenchymal Stem Cell Transplantation in Reducing Venous Neointimal Hyperplasia Associated with Arteriovenous Fistula
Binxia Yang et al.
RADIOLOGY (2016)
In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models
Carlos Perez-Medina et al.
JACC-CARDIOVASCULAR IMAGING (2016)
Extracellular domain shedding influences specific tumor uptake and organ distribution of the EGFR PET tracer 89Zr-imgatuzumab
Martin Pool et al.
ONCOTARGET (2016)
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling
Edward K. Fung et al.
EJNMMI RESEARCH (2016)
Radioimmunotherapy of Metastatic Prostate Cancer with 177Lu-DOTA-huJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody
Shankar Vallabhajosula et al.
CURRENT RADIOPHARMACEUTICALS (2016)
B-cell imaging withzirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients
Stefan Bruijnen et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Tumor-Infiltrating Lymphocyte Therapy: Addressing Prevailing Questions
Laszlo G. Radvanyi
CANCER JOURNAL (2015)
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
Neeta Pandit-Taskar et al.
CLINICAL CANCER RESEARCH (2015)
PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of 89Zr-Cetuximab
Nikolaos E. Makris et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
PET Imaging of Tumor-Associated Macrophages with Zr-89-Labeled High-Density Lipoprotein Nanoparticles
Carlos Perez-Medina et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
Richard Tavare et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
89Zr-cetuximab PET imaging in patients with advanced colorectal cancer
Catharina Willemien Menke-van der Houven van Oordt et al.
ONCOTARGET (2015)
The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies
Brian M. Zeglis et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
Novel 89Zr cell labeling approach for PET-based cell trafficking studies
Aditya Bansal et al.
EJNMMI RESEARCH (2015)
Heterogeneity of intratumoral 111In-ibritumomab tiuxetan and 18F-FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell non-Hodgkin's lymphoma
Kohei Hanaoka et al.
EJNMMI RESEARCH (2015)
89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment
Sjoukje F. Oosting et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy
Punit Sharma et al.
PET CLINICS (2015)
A solid target system with remote handling of irradiated targets for PET cyclotrons
J. Siikanen et al.
APPLIED RADIATION AND ISOTOPES (2014)
Molecular Pathways: HER3 Targeted Therapy
Kinisha Gala et al.
CLINICAL CANCER RESEARCH (2014)
89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
Neeta Pandit-Taskar et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
A Prospective Pilot Study of 89Zr-J591/Prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy
Joseph R. Osborne et al.
JOURNAL OF UROLOGY (2014)
Noninvasive Imaging of PSMA in Prostate Tumors with 89Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives
Nerissa Therese Viola-Villegas et al.
MOLECULAR PHARMACEUTICS (2014)
Evaluation of 89Zr-pertuzumab in Breast Cancer Xenografts
Bernadette V. Marquez et al.
MOLECULAR PHARMACEUTICS (2014)
Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys Prelude to Phase 1 clinical studies
Danielle J. Vugts et al.
MABS (2014)
Mapping biological behaviors by application of longer-lived positron emitting radionuclides
Yang Zhou et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
ImmunoPET Imaging of Renal Cell Carcinoma with 124I- and 89Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice
Alexander B. Stillebroer et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques
Maulik D. Majmudar et al.
CIRCULATION RESEARCH (2013)
89Zr- Bevacizumab PET Imaging in Primary Breast Cancer
Sietske B. M. Gaykema et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET
Yelena Y. Janjigian et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Pilot Study on the Feasibility of PET/CT Lymphoscintigraphy with 89Zr-Nanocolloidal Albumin for Sentinel Node Identification in Oral Cancer Patients
Derrek A. Heuveling et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Feasibility of Vascular Endothelial Growth Factor Imaging in Human Atherosclerotic Plaque Using 89Zr-Bevacizumab Positron Emission Tomography
Reza Golestani et al.
MOLECULAR IMAGING (2013)
Measurement of Tumor VEGF-A Levels with 89Zr-Bevacizumab PET as an Early Biomarker for the Antiangiogenic Effect of Everolimus Treatment in an Ovarian Cancer Xenograft Model
Arne R. M. van der Bilt et al.
CLINICAL CANCER RESEARCH (2012)
Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET
Saiyada N. F. Rizvi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
PET and MRI of Metastatic Peritoneal and Pulmonary Colorectal Cancer in Mice with Human Epidermal Growth Factor Receptor 1-Targeted Zr-89-Labeled Panitumumab
Tapan K. Nayak et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Lapatinib and 17AAG Reduce 89Zr-Trastuzumab-F(ab')2 Uptake in SKBR3 Tumor Xenografts
Thijs H. Oude Munnink et al.
MOLECULAR PHARMACEUTICS (2012)
89Zr-Labeled Dextran Nanoparticles Allow in Vivo Macrophage Imaging
Edmund J. Keliher et al.
BIOCONJUGATE CHEMISTRY (2011)
VEGF-PET Imaging Is a Noninvasive Biomarker Showing Differential Changes in the Tumor during Sunitinib Treatment
Wouter B. Nagengast et al.
CANCER RESEARCH (2011)
In vivo Biodistribution of Stem Cells Using Molecular Nuclear Medicine Imaging
Mick M. Welling et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Targeting the Internal Epitope of Prostate-Specific Membrane Antigen with 89Zr-7E11 Immuno-PET
Alessandro Ruggiero et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
89Zr-Nanocolloidal Albumin-Based PET/CT Lymphoscintigraphy for Sentinel Node Detection in Head and Neck Cancer: Preclinical Results
Derrek A. Heuveling et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
In vivo biodistribution and accumulation of 89Zr in mice
Diane S. Abou et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
A Pretherapy Biodistribution and Dosimetry Study of Indium-111-Radiolabeled Trastuzumab in Patients with Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer
Jeffrey Y. C. Wong et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2010)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Cerenkov Luminescence Imaging of Medical Isotopes
Alessandro Ruggiero et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
Jason P. Holland et al.
PLOS ONE (2010)
CD20-Targeted Therapy: The Next Generation of Antibodies
Tom van Meerten et al.
SEMINARS IN HEMATOLOGY (2010)
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
Eli C. F. Dijkers et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Preparation and evaluation of 89Zr-Zevalin for monitoring of 90Y-Zevalin biodistribution with positron emission tomography
Lars R. Perk et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients
PKE Börjesson et al.
CLINICAL CANCER RESEARCH (2006)
Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs
F Ciardiello et al.
EUROPEAN JOURNAL OF CANCER (2003)
The role of B cells in rheumatoid arthritis:: mechanisms and therapeutic targets
T Dörner et al.
CURRENT OPINION IN RHEUMATOLOGY (2003)
分享论文
